Hanson McClain Advisors »

Vaneck Vectors Pharmaceutical etf shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Vaneck Vectors Pharmaceutical etf (PPH) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Vaneck Vectors Pharmaceutical etf

Tip: Access up to 7 years of quarterly data

All positions including Vaneck Vectors Pharmaceutical etf held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vaneck Vectors Pharmaceutical etf by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $33k 349 95.03
2024-06-30 $32k 349 91.90
2024-03-31 $32k 349 90.70
2023-12-31 $28k 349 81.37
2023-06-30 $5.8k 74 78.77

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Spdr Ser Tr Prtflo S&p500 Vl (SPYV)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Mbs Etf (MBB)
Apple (AAPL)
Spdr Index Shs Fds Portfolio Emg Mk (SPEM)
2023 Etf Series Trust Ii Gmo Us Quality E (QLTY)
Ishares Tr Usd Inv Grde Etf (USIG)
Invesco Exch Traded Fd Tr Ii S&p 500 Revenue (RWL)
Ishares Tr Core S&p Ttl Stk (ITOT)

View all positions for Hanson McClain Advisors

Top funds holding Vaneck Vectors Pharmaceutical etf

Goldman Sachs Group
Healthcare Of Ontario Pension Plan Trust Fund
Avalon Trust
Mirae Asset Global Investments
Thrivent Financial for Lutherans
Miller Investment Management
Northwestern Mutual Wealth Management Company
Prime Capital Investment Advisors
Bank of America Corporation
Financial Partners Group
LPL Financial
Mivtachim The Workers Social Insurance Fund
Phoenix Holdings
Morgan Stanley
J.Safra Asset Management

View all funds holding Vaneck Vectors Pharmaceutical etf